Munkonda MN - Search Results

1

2-Hexylthio-β,γ-CH2-ATP is an effective and selective NTPDase2 inhibitor.

Gillerman I, Lecka J, Simhaev L, Munkonda MN, Fausther M, Martín-Satué M, Senderowitz H, Sévigny J, Fischer B. Gillerman I, et al. Among authors: munkonda mn. J Med Chem. 2014 Jul 24;57(14):5919-34. doi: 10.1021/jm401933c. Epub 2014 Jul 14. J Med Chem. 2014. PMID: 24972256

2

Fluorescent N2,N3-epsilon-adenine nucleoside and nucleotide probes: synthesis, spectroscopic properties, and biochemical evaluation.

Sharon E, Lévesque SA, Munkonda MN, Sévigny J, Ecke D, Reiser G, Fischer B. Sharon E, et al. Among authors: munkonda mn. Chembiochem. 2006 Sep;7(9):1361-74. doi: 10.1002/cbic.200600070. Chembiochem. 2006. PMID: 16871613 Free PMC article.

3

Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide.

Brunschweiger A, Iqbal J, Umbach F, Scheiff AB, Munkonda MN, Sévigny J, Knowles AF, Müller CE. Brunschweiger A, et al. Among authors: munkonda mn. J Med Chem. 2008 Aug 14;51(15):4518-28. doi: 10.1021/jm800175e. Epub 2008 Jul 17. J Med Chem. 2008. PMID: 18630897 Free PMC article.

4

8-BuS-ATP derivatives as specific NTPDase1 inhibitors.

Lecka J, Gillerman I, Fausther M, Salem M, Munkonda MN, Brosseau JP, Cadot C, Martín-Satué M, d'Orléans-Juste P, Rousseau E, Poirier D, Künzli B, Fischer B, Sévigny J. Lecka J, et al. Among authors: munkonda mn. Br J Pharmacol. 2013 May;169(1):179-96. doi: 10.1111/bph.12135. Br J Pharmacol. 2013. PMID: 23425137 Free PMC article.

5

Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists.

Munkonda MN, Kauffenstein G, Kukulski F, Lévesque SA, Legendre C, Pelletier J, Lavoie EG, Lecka J, Sévigny J. Munkonda MN, et al. Biochem Pharmacol. 2007 Nov 15;74(10):1524-34. doi: 10.1016/j.bcp.2007.07.033. Epub 2007 Jul 27. Biochem Pharmacol. 2007. PMID: 17727821

6

Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3 : partial characterization of the inhibitory epitope and potential applications.

Munkonda MN, Pelletier J, Ivanenkov VV, Fausther M, Tremblay A, Künzli B, Kirley TL, Sévigny J. Munkonda MN, et al. FEBS J. 2009 Jan;276(2):479-96. doi: 10.1111/j.1742-4658.2008.06797.x. FEBS J. 2009. PMID: 19120451 Free PMC article.

7

Recombinant acylation stimulating protein administration to C3-/- mice increases insulin resistance via adipocyte inflammatory mechanisms.

Munkonda MN, Lapointe M, Miegueu P, Roy C, Gauvreau D, Richard D, Cianflone K. Munkonda MN, et al. PLoS One. 2012;7(10):e46883. doi: 10.1371/journal.pone.0046883. Epub 2012 Oct 8. PLoS One. 2012. PMID: 23056509 Free PMC article.

8

The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice.

Paglialunga S, Fisette A, Munkonda M, Gao Y, Richard D, Cianflone K. Paglialunga S, et al. BMC Physiol. 2010 Apr 23;10:4. doi: 10.1186/1472-6793-10-4. BMC Physiol. 2010. PMID: 20416070 Free PMC article.

9

Amylin stimulates fatty acid esterification in 3T3-L1 adipocytes.

Miegueu P, St-Pierre DH, Munkonda MN, Lapointe M, Cianflone K. Miegueu P, et al. Among authors: munkonda mn. Mol Cell Endocrinol. 2013 Feb 5;366(1):99-107. doi: 10.1016/j.mce.2012.12.008. Epub 2012 Dec 20. Mol Cell Endocrinol. 2013. PMID: 23261986

10

C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue.

Poursharifi P, Lapointe M, Fisette A, Lu H, Roy C, Munkonda MN, Fairlie DP, Cianflone K. Poursharifi P, et al. Among authors: munkonda mn. Mol Cell Endocrinol. 2014 Jan 25;382(1):325-333. doi: 10.1016/j.mce.2013.10.019. Epub 2013 Oct 25. Mol Cell Endocrinol. 2014. PMID: 24397921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page